How Johnson & Johnson Failed to Exclude Key Plaintiffs’ Experts - A Daubert claim was filed in which J & J asked that some of the experts on the Plaintiffs’ side should be disqualified as experts, therefore unable to testify. The judge in the case did not exclude these experts. The goal in this—and any other—Daubert Hearing is to evaluate whether the expert witnesses and their evidence are credible. If Johnson & Johnson had prevailed at this particular Daubert Hearing, almost 12,000 talcum powder ovarian cancer lawsuits could have been dismissed—79 percent of the total of all the outstanding baby powder ovarian cancer lawsuits.

The long-awaited Daubert decision was given by Chief Judge Wolfson, the judge overseeing the Johnson & Johnson baby powder ovarian cancer multidistrict litigation at the end of April 2020. Wolfson gave a 141-page opinion that comprehensively analyzed the factors which will determine whether scientific expert witnesses (both for the plaintiffs and for the defendants) will be allowed to testify on various issues that are critical to the cases pending on baby powder ovarian cancer...

According to Drug Safety News, a recently published article in the journal Reproductive Sciences has possibly determined how talc exposure can lead to ovarian cancer. Three female scientists working at Detroit’s Wayne State University have devoted years of research in an attempt to understand how a woman’s exposure to talc can potentially lead to ovarian cancer. The researchers studied the in vitro application of talc—both to cancerous ovarian cells as well as to healthy cells.

August 31, 2020 - CA-125 stands for Cancer Antigen 125 and is a protein that can be found in higher levels in the blood of women who have ovarian cancer. CA-125 is released into the bloodstream after being produced on the cell surfaces. In about three-quarters of women who have advanced ovarian cancer, the CA-125 will be elevated, and in about half of those with early-stage ovarian cancer, the CA-125 will be elevated. As you can see, while a CA-125 screening test could be useful, it is certainly not without its problems since it can miss half of all early ovarian cancers...

August 09, 2020 - In July 2018, a St. Louis jury awarded nearly $4.7 billion ($4.14 billion in punitive damages and $550 million in compensatory damages) to 22 women and their families, after those women claimed asbestos in Johnson & Johnson’s talcum powder contributed to their ovarian cancer. Up until now, the ovarian cancer claims against J & J focused on the talc fibers, rather than asbestos.